Post hoc analysis determined that treatment with fingolimod reduced the level of APP in the cortex of 3xTg-AD mice (Veh: 105.7 ± 12.29, FTY: 59.38 ± 4.99; p = 0.0051, n = 3). The gene discussed is APP; the disease is Alzheimer disease.